Ascletis Pharma Inc.
ASCLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$301 | -$145 | -$315 | -$199 |
| Dep. & Amort. | $20 | $18 | $30 | $30 |
| Deferred Tax | $0 | $0 | $0 | $48 |
| Stock-Based Comp. | $3 | $1 | $3 | $7 |
| Change in WC | $14 | $39 | $34 | -$10 |
| Other Non-Cash | -$78 | -$58 | $105 | -$22 |
| Operating Cash Flow | -$342 | -$144 | -$142 | -$147 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$6 | -$14 | -$7 |
| Net Acquisitions | $0 | $0 | $0 | $2 |
| Inv. Purchases | -$638 | -$997 | -$1,762 | -$602 |
| Inv. Sales/Matur. | $1,497 | $1,166 | $479 | $332 |
| Other Inv. Act. | $121 | -$13 | $0 | $0 |
| Investing Cash Flow | $979 | $150 | -$1,297 | -$274 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$5 | -$2 | -$2 | -$2 |
| Stock Issued | $0 | $0 | $1 | $0 |
| Stock Repurch. | -$99 | -$79 | $0 | -$29 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$0 | -$0 | -$0 |
| Financing Cash Flow | -$104 | -$81 | -$1 | -$31 |
| Forex Effect | $0 | $2 | $118 | -$31 |
| Net Chg. in Cash | $534 | -$74 | -$1,324 | -$483 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $330 | $404 | $1,727 | $2,211 |
| End Cash | $864 | $330 | $404 | $1,727 |
| Free Cash Flow | -$344 | -$163 | -$157 | -$154 |